Legislation and supervision
The work of the blood services is strictly regulated, with the authorities exercising control through regular checks. Legislation and controls are designed to ensure the safety of blood products from the viewpoint of the patient.
Directive 2002/98/EC of the European Parliament and the Council of 27 January 2003, setting out standards of quality and safety for the collection, testing, processing, storage and distribution of human blood and blood components and amending Directive 2001/83/EC, is known as the Blood Directive. This directive seeks to harmonise the quality requirements for legislation and practices regarding blood services in the European Union member states.
As its name suggests, the Blood Directive addresses issues related to the safety of blood products. It issues guidance on blood donors, blood donation, the production and conservation of blood products, as well as on their distribution to hospitals. The directive also provides for the tracking of blood products from the donor to the patient and vice versa and for the quality requirements and safety standards set for blood services.
The European Commission has set up a regulatory committee of experts representing the member countries, tasked with ensuring, with the aid of directives issued by the Commission, that the detailed regulations on blood services remain up to date and that they take account of the most recent research and technology.
In Finland, blood services are supervised by the Finnish Medicines Agency Fimea.